Jin Medical International Ltd. cash flow statement

In fiscal 2025, Jin Medical International Ltd.'s operations generated $2.9m of cash; it spent $6.6m on capital projects, leaving free cash flow of −$3.7m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Jin Medical International Ltd.: cash flow statement, annual
Fiscal year	2021Sept 2021	2022Sept 2022	2023Sept 2023	2024Sept 2024	2025Sept 2025
Cash from operations	5,843	1,581	3,106	−1,207	2,904
Depreciation and amortisation	347	363	226	238	243
Capital spending	43	40	114	145	6,630
Free cash flow	5,800	1,540	2,992	−1,352	−3,726
Shares issued	—	—	—	312	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: NEPH vs ZJYL VVOS vs ZJYL SNOA vs ZJYL SRTS vs ZJYL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Jin Medical International Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Jin Medical International Ltd.